Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days 1.22€ 1.22€ Friday, 22nd Dec 2023 PHGN.F stock ended at 1.22€. During the day the stock fluctuated 0% from a day low at 1.22€ to a day high of 1.22€.
90 days 1.20€ 1.22€
52 weeks 0.92€ 1.48€

Historical Pharming Group N.V. prices

Date Open High Low Close Volume
Aug 19, 2019 1.15€ 1.15€ 1.13€ 1.15€ 5 000
Aug 16, 2019 1.12€ 1.14€ 1.12€ 1.14€ 40 000
Aug 15, 2019 1.07€ 1.09€ 1.07€ 1.09€ 40 000
Aug 14, 2019 1.13€ 1.13€ 1.11€ 1.11€ 500
Aug 13, 2019 1.17€ 1.18€ 1.13€ 1.18€ 4 400
Aug 12, 2019 1.11€ 1.12€ 1.11€ 1.12€ 6 500
Aug 09, 2019 1.11€ 1.11€ 1.10€ 1.10€ 0
Aug 08, 2019 1.06€ 1.09€ 1.06€ 1.09€ 22 740
Aug 07, 2019 1.04€ 1.06€ 1.02€ 1.02€ 20 000
Aug 06, 2019 0.99€ 1.04€ 0.99€ 1.04€ 0
Aug 05, 2019 1.00€ 1.01€ 1.00€ 1.01€ 500
Aug 02, 2019 1.00€ 1.03€ 1.00€ 1.01€ 0
Aug 01, 2019 1.00€ 1.03€ 1.00€ 1.02€ 500
Jul 31, 2019 0.97€ 1.00€ 0.96€ 1.00€ 3 000
Jul 30, 2019 1.06€ 1.06€ 0.96€ 0.96€ 30 200
Jul 29, 2019 0.94€ 1.04€ 0.94€ 1.04€ 2 500
Jul 26, 2019 0.93€ 0.94€ 0.93€ 0.94€ 0
Jul 25, 2019 0.87€ 0.93€ 0.87€ 0.92€ 4 000
Jul 24, 2019 0.83€ 0.83€ 0.80€ 0.80€ 0
Jul 23, 2019 0.81€ 0.83€ 0.81€ 0.83€ 900
Click to get the best stock tips daily for free!

About Pharming Group N.V.

Pharming Group N.V. Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema. It also engages in the development of rhC1INH for the treatment ... PHGN.F Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT